Gary Peters is not exactly dominating the news cycle right now. Zero Google News stories in the last 24 hours. A handful of Bluesky posts, mostly people complaining he's boring on television. Which is fine. Boring senators file boring disclosures. Except Peters dropped three trades on a single day in April, two of which land squarely inside his committee jurisdiction, and his overall alpha record across nine scored trades runs negative. The trades are public. The committee assignments are public. The calendar is public. Put them next to each other and see what you think.
Three Trades. One Day. Two Flags.
On April 23, 2026, Peters filed three separate disclosures simultaneously: a sale of Corteva Agriscience (CTVA) in the 5K-$50K range, a purchase of J.M. Smucker (SJM) in the K-5K range, and a purchase of PepsiCo (PEP) in the 5K-$50K range.
Two of those three trades carry committee overlap flags in Peters's full disclosure record on Blind Trust. The Corteva sale overlaps with his seat on the Senate Appropriations subcommittee covering Agriculture, Rural Development, Food and Drug Administration, and Related Agencies. The PepsiCo purchase carries a Food & Beverage, Consumer overlap tied to the same committee remit.
Corteva makes crop protection chemicals and seeds. PepsiCo makes Lay's and Gatorade. The Senate Agriculture Appropriations subcommittee writes the checks that fund the FDA's food safety oversight and the USDA programs those companies operate inside. Peters sits on it.
Members are required to disclose. They are not required to divest, recuse, abstain, or look mildly uncomfortable about any of this. That's the rule. Yes, really.
The Corteva Sale: Exiting an Ag Name at a Bad Time
The Corteva sale is the trade that draws the sharpest line. Peters sold CTVA on April 23. Per the alpha record, that sale generated negative 5.6% excess return against the S&P 500 over the following 30 days, meaning the stock outperformed the index after he sold it. He sold. The stock did better than the market. That's not a winning trade.
It's also the trade with the clearest committee fingerprint. Corteva is an agricultural inputs company, operating in exactly the sector Peters's Appropriations subcommittee funds and oversees. The overlap is listed in the filing. The performance is in the data. The interpretation is yours.
The PepsiCo Buy: 5K-$50K Into a Name His Committee Touches
The PepsiCo purchase on the same day is the other flagged trade. Peters bought 5K-$50K of PEP on April 23. Thirty-day alpha on that trade: positive 0.4%. Barely above flat versus the S&P. Not a barnburner. But the committee overlap is real: PepsiCo is a major packaged food and beverage company subject to FDA oversight, and Peters sits on the subcommittee that funds the FDA's food safety programs.
The Venn diagram of "senator who funds FDA food programs" and "senator who buys the stock of a company the FDA regulates" is one circle, not two.
The J.M. Smucker purchase, the third trade filed that day in the K-5K range, carries no committee overlap flag in the data. It's just a trade.
The Broader Alpha Record: Not Pretty
Zoom out from April 23 and the picture doesn't improve. Peters's scored trade history across nine trades shows 5 positive alpha outcomes and 4 negative, with a mean 30-day alpha of negative 3.4%. The median senator would rather not have that number public. Peters apparently doesn't mind.
The best trades in the sample: a Stanley Black & Decker (SWK) purchase on January 12, 2026 that printed plus 9.2% excess return, and a W. P. Carey (WPC) purchase the same day at plus 7.3%. Both carry zero committee overlap. They're just trades that happened to work. No angle, no story, just two names that went up.
The worst: an Organon & Co. (OGN) sale on October 7, 2025 that generated negative 39.9% alpha over 30 days. That means OGN outperformed the S&P by nearly 40 points in the month after Peters sold it. No committee overlap on that one either. Just a trade that went spectacularly wrong.
The INTC sale on December 12, 2025 carries a Technology committee overlap flag and a negative 5.8% alpha. Same pattern as Corteva: a committee-adjacent name sold at a bad time relative to the market.
5 wins out of 9 scored trades. Minus 3.4% mean alpha. The record is what it is.
What Peters Has Been Voting On
The floor votes in the same window are worth a look, even where the committee angle doesn't apply.
On May 13, 2026, Peters voted Yea on three separate motions to proceed related to Congressional Review Act resolutions targeting CFPB rule rollbacks: one on medical debt collection practices, one on overdraft opt-in disclosures, and one on servicemember financial protections. All three motions were rejected. Peters was on the losing side of all three.
On June 3, Peters voted Yea on a motion to proceed on a CRA resolution targeting an EPA rollback of hazardous air pollutant standards for coal and oil-fired power plants. Also rejected.
None of those votes connect to his disclosed trades in any direct way. Peters doesn't sit on the Banking Committee. The CFPB votes are floor votes outside his committee remit. Same with the EPA vote. A floor vote is just a floor vote.
He also voted three times in favor of directing the removal of U.S. Armed forces from hostilities against Iran, twice unsuccessfully and once on a discharge motion that passed on May 19. His committee work on Armed Services is relevant context there, but no trade in the record touches defense or energy names flagged to that committee.
The Deadpan Part
Peters is not in the news today. Social media has approximately three posts mentioning him, two of which are about whether he's boring enough on cable television and one speculating about a hypothetical re-election campaign for a seat he's retiring from. The public record of his trades is generating more narrative than anything he actually said this week.
There's no single shocking trade, no whale move, no obvious one-day pop around a disclosure. What the data shows is a senator on the Agriculture Appropriations subcommittee selling an agricultural inputs company and buying a food conglomerate on the same day, with an overall trading record that runs negative against the market.
The committee overlap trades specifically: CTVA down 5.6% alpha (sold), PEP up 0.4% alpha (bought), VZ down 1.4% alpha (bought in December, Telecom overlap from his Commerce subcommittee seat), INTC down 5.8% alpha (sold in December, Technology overlap). Combined: the committee-adjacent trades haven't been Peters's best work.
You can review every disclosed trade Peters has filed and score them yourself. The data is not going anywhere.
The Structural Thing Nobody Talks About
Peters sits on four distinct Appropriations subcommittees: Agriculture, Commerce/Justice/Science, Homeland Security, and Energy/Water. He's also on Armed Services and the full Commerce committee, which covers telecommunications, manufacturing, and surface transportation.
That's a lot of sectors. A lot of companies. A lot of potential overlap between the legislative calendar and a personal brokerage account. The STOCK Act requires disclosure within 45 days. It does not require divestiture. It does not require recusal. It does not require any acknowledgment that the overlap exists.
The system is built this way on purpose, by the people who benefit from it being built this way. Peters is one of them. So is almost everyone else on the Hill who files these disclosures while holding the pen on the budgets that affect the same companies.
The receipts are public. Make of them what you make of them.